|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
06667 MEGA GENOMICS
Nominal 
7.710 +0.010 (+0.130%) | 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | |
| Turnover | 107,291 | 8.507% | 98,879 | 97,617 | 96,831 |
| Cost of Sales | (37,673) | 12.189% | (33,580) | (33,201) | (32,419) |
| Gross Profit | 69,618 | 6.614% | 65,299 | 64,416 | 64,412 |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | (15,174) | (2,045) | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 43,042 | 1.749% | 42,302 | 20,781 | 42,494 | |
| Taxation | (6,073) | -15.477% | (7,185) | (2,981) | (7,180) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 36,969 | 5.274% | 35,117 | 17,800 | 35,314 | |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | |
| Net Finance Costs / (Income) | 284 | -- | (95) | (387) | 6,449 |
| Depreciation & Amortisation | 7,196 | -5.091% | 7,582 | 7,756 | 6,931 |
| Directors' Emoluments | -- | -- | -- | -- | -- |
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/06 | 2022/06 | 2021/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A |
Market Valuation Indicators
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/06 | 2022/06 | 2021/06 | |
| EPS (cts) | 18.000 | 12.500% | 16.000 | 9.000 | 66.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | -- |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- |
| NBV per share ($) | 2.804 | -- | 2.745 | 2.711 | -- |
| Remarks: | Real time quote last updated: 13/11/2024 16:51 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB 36,969,000 |
| %Change | 5.274% |
| EPS / (LPS) | RMB 0.180 |
| NBV Per Share (¥) | RMB 2.804 |